In conclusion, the oncogenic BCR-ABL activation results in DNA damage, but despite proposed partial reduction of ATR-Chk1 activity, the ATM-Chk2-mediated signaling to p53 and other DDR effectors appears to respond to threshold of genotoxic insults, providing a checkpoint barrier against transformation into BC. The gene discussed is CHEK2; the disease is breast cancer.